Cite This        Tampung        Export Record
Judul Respon pembentukan antibodi pada tikus putih terhadap vaksin ompA-Recombinant Feline Chlamydiosis
Pengarang Pudjiatmoko
EDISI vol. 8, p.8-14
Penerbitan Bogor BBPMSOH 2001
Deskripsi Fisik 4 tables. 11 ref.; Summary (En)
ISBN 0852-9612
Subjek Cats -- Escherichia coli -- Rats -- ANTIBODIES -- IMMUNO FLUORESCENCE -- Chlamydia Psittaci -- Bacteriosis -- Synthetic Vaccine -- Protein -- Specific Pathogen Free State
Catatan The omp A-recombinant protein produced by E.coli BL21 (DE3)plysS containing pRSETA/ompA gene of feline Chlamydia psittaci B166 strain was purified using method of Xpress system protein purification (invitrogen BV, The Netherlands). To eliminate guanidine hydrochloride, the suspension of ompA-recombinant protein was dialyzed in 20 mM Tris pH 7.8, glycerol 10% and phenylmethylsulfonyl fluoride containing 0,1 M Mgcl2, CaCl2, NaCl or KCl. To prepare the vaccines, the purified proteins were emulsified with oil adjuvant. One ml of each vaccine was injected intramuscularly to 4 spesific pathogen free rats 8-week-old. The second vaccination was performed at 3 weeks post first vaccination. IgG antibody titer against feline Chlamydia psittaci was measured using microimmunofluorescene test at a week post second vaccination. Vaccination using ompA-recombinant could initiate IgG antibody in 21 of 24 vaccinated rats. IgG antibody titer or rats vaccinated with materials dialyzed in dialysis buffer containing KCl has highest
Bentuk Karya Tidak ada kode yang sesuai
Target Pembaca Tidak ada kode yang sesuai

 
No Barcode No. Panggil Akses Lokasi Ketersediaan
Tag Ind1 Ind2 Isi
001 INLIS000000000000081
005 20210323091255
008 210323||||||||| | ||| |||| || |
020 $a 0852-9612
035 0010-0321000081
041 $a id
100 0 $a Pudjiatmoko
245 0 0 $a Respon pembentukan antibodi pada tikus putih terhadap vaksin ompA-Recombinant Feline Chlamydiosis
250 $a vol. 8, p.8-14
260 $a Bogor $b BBPMSOH $c 2001
300 $a 4 tables. 11 ref.; Summary (En)
500 $a The omp A-recombinant protein produced by E.coli BL21 (DE3)plysS containing pRSETA/ompA gene of feline Chlamydia psittaci B166 strain was purified using method of Xpress system protein purification (invitrogen BV, The Netherlands). To eliminate guanidine hydrochloride, the suspension of ompA-recombinant protein was dialyzed in 20 mM Tris pH 7.8, glycerol 10% and phenylmethylsulfonyl fluoride containing 0,1 M Mgcl2, CaCl2, NaCl or KCl. To prepare the vaccines, the purified proteins were emulsified with oil adjuvant. One ml of each vaccine was injected intramuscularly to 4 spesific pathogen free rats 8-week-old. The second vaccination was performed at 3 weeks post first vaccination. IgG antibody titer against feline Chlamydia psittaci was measured using microimmunofluorescene test at a week post second vaccination. Vaccination using ompA-recombinant could initiate IgG antibody in 21 of 24 vaccinated rats. IgG antibody titer or rats vaccinated with materials dialyzed in dialysis buffer containing KCl has highest titer ranged from 1:16 to 1:64, and its geometric mean titer is 1:38. The results of the present study indicate that the ompA-recombinant protein of chlamydia used for main component of vaccine my initiate antibody against feline C. psittaci in rats
650 0 $a Cats -- Escherichia coli -- Rats -- ANTIBODIES -- IMMUNO FLUORESCENCE -- Chlamydia Psittaci -- Bacteriosis -- Synthetic Vaccine -- Protein -- Specific Pathogen Free State
Content Unduh katalog